These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26542526)

  • 1. Mismatch negativity (MMN) as biomarker predicting psychosis in clinically at-risk individuals.
    Näätänen R; Todd J; Schall U
    Biol Psychol; 2016 Apr; 116():36-40. PubMed ID: 26542526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis.
    Atkinson RJ; Michie PT; Schall U
    Biol Psychiatry; 2012 Jan; 71(2):98-104. PubMed ID: 22000060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurophysiological biomarkers support bipolar-spectrum disorders within psychosis cluster.
    Kaur M; Battisti RA; Lagopoulos J; Ward PB; Hickie IB; Hermens DF
    J Psychiatry Neurosci; 2012 Sep; 37(5):313-21. PubMed ID: 22469054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch negativity/P3a complex in young people with psychiatric disorders: a cluster analysis.
    Kaur M; Lagopoulos J; Ward PB; Watson TL; Naismith SL; Hickie IB; Hermens DF
    PLoS One; 2012; 7(12):e51871. PubMed ID: 23251645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
    Kaur M; Battisti RA; Ward PB; Ahmed A; Hickie IB; Hermens DF
    Schizophr Res; 2011 Aug; 130(1-3):203-9. PubMed ID: 21550211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD.
    Rydkjær J; Møllegaard Jepsen JR; Pagsberg AK; Fagerlund B; Glenthøj BY; Oranje B
    Psychol Med; 2017 Jan; 47(2):377-388. PubMed ID: 27776572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced duration mismatch negativity in adolescents with psychotic symptoms: further evidence for mismatch negativity as a possible biomarker for vulnerability to psychosis.
    Murphy JR; Rawdon C; Kelleher I; Twomey D; Markey PS; Cannon M; Roche RA
    BMC Psychiatry; 2013 Feb; 13():45. PubMed ID: 23375130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity.
    Perez VB; Woods SW; Roach BJ; Ford JM; McGlashan TH; Srihari VH; Mathalon DH
    Biol Psychiatry; 2014 Mar; 75(6):459-69. PubMed ID: 24050720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMN and P3a Elicited by a Novelty Oddball Paradigm Are Not Reduced in Early-Phase Psychosis.
    Riel H; Rudolph E; MacPhee C; Tibbo PG; Fisher DJ
    Neuropsychobiology; 2022; 81(6):506-515. PubMed ID: 36380625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.
    Light GA; Swerdlow NR; Thomas ML; Calkins ME; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Pela M; Radant AD; Seidman LJ; Sharp RF; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Tsuang DW; Tsuang MT; Braff DL; Turetsky BI
    Schizophr Res; 2015 Apr; 163(1-3):63-72. PubMed ID: 25449710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitch and Duration Mismatch Negativity and Premorbid Intellect in the First Hospitalized Schizophrenia Spectrum.
    Salisbury DF; Polizzotto NR; Nestor PG; Haigh SM; Koehler J; McCarley RW
    Schizophr Bull; 2017 Mar; 43(2):407-416. PubMed ID: 27231308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mismatch negativity (MMN) as a tool for translational investigations into early psychosis: A review.
    Tada M; Kirihara K; Mizutani S; Uka T; Kunii N; Koshiyama D; Fujioka M; Usui K; Nagai T; Araki T; Kasai K
    Int J Psychophysiol; 2019 Nov; 145():5-14. PubMed ID: 30831138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatch Negativity But Not P300 Is Associated With Functional Disability in Schizophrenia.
    Hamilton HK; Perez VB; Ford JM; Roach BJ; Jaeger J; Mathalon DH
    Schizophr Bull; 2018 Apr; 44(3):492-504. PubMed ID: 29036701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizotypy and auditory mismatch negativity in a non-clinical sample of young adults.
    Broyd SJ; Michie PT; Bruggemann J; van Hell HH; Greenwood LM; Croft RJ; Todd J; Lenroot R; Solowij N
    Psychiatry Res Neuroimaging; 2016 Aug; 254():83-91. PubMed ID: 27388803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of glycine on auditory mismatch negativity in schizophrenia.
    Greenwood LM; Leung S; Michie PT; Green A; Nathan PJ; Fitzgerald P; Johnston P; Solowij N; Kulkarni J; Croft RJ
    Schizophr Res; 2018 Jan; 191():61-69. PubMed ID: 28602646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditory Mismatch Negativity and P300a Elicited by the "Optimal" Multi-feature Paradigm in Early Schizophrenia.
    Fisher DJ; Campbell DJ; Abriel SC; Ells EML; Rudolph ED; Tibbo PG
    Clin EEG Neurosci; 2018 Jul; 49(4):238-247. PubMed ID: 29502452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed preattentional functioning in early psychosis patients with cannabis use.
    Pesa N; Hermens DF; Battisti RA; Kaur M; Hickie IB; Solowij N
    Psychopharmacology (Berl); 2012 Aug; 222(3):507-18. PubMed ID: 22402706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced P3a amplitudes in antipsychotic naïve first-episode psychosis patients and individuals at clinical high-risk for psychosis.
    Mondragón-Maya A; Solís-Vivanco R; León-Ortiz P; Rodríguez-Agudelo Y; Yáñez-Téllez G; Bernal-Hernández J; Cadenhead KS; de la Fuente-Sandoval C
    J Psychiatr Res; 2013 Jun; 47(6):755-61. PubMed ID: 23507048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis.
    Nagai T; Tada M; Kirihara K; Yahata N; Hashimoto R; Araki T; Kasai K
    Schizophr Res; 2013 Nov; 150(2-3):547-54. PubMed ID: 24012461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.